Generative artificial intelligence (GenAI) is currently transforming the life sciences industry not only technologically, but also organisationally and culturally. Research and development are being accelerated, personalised medicine is becoming accessible to a larger target group, and productivity is increasing significantly in many areas. Organisations are therefore faced with the task of adapting structures, expanding skills and providing targeted further training for employees.
In the English-language white paper "GenAI Unleashed – Catalysing Innovation in the Life Sciences Industry", we show how companies can secure competitive advantages. Practical examples and current market data provide insights into the state of AI implementation, the transformation of organisations, and the requirements for future-proof teams.